Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.

Abstract

2CdA is highly active in previously untreated patients with Waldenström's macroglobulinemia. A limited program of treatment induced responses of good quality and long duration in more than 80% of patients.